USD 250.8 million
Exosomes Market Size, Share, Growth Analysis, By Product (Kits & Reagents, Instruments), By Workflow (Isolation Methods, Downstream Analysis), By Application (Cancer, Cardiovascular Diseases (CVD)), By End-Use, By Region - Industry Forecast 2024-2031
Report ID:
SQMIG35H2198 |
Region:
Global |
Published Date: February, 2024
Pages:
157
|Tables:
90
|Figures:
76
Exosomes Market Insights
Global Exosomes Market size was valued at USD 250.8 million in 2022 and is poised to grow from USD 325.79 million in 2023 to USD 2641.25 million by 2031, growing at a CAGR of 29.9% during the forecast period (2024-2031).
Extracellular vesicles (EVs), another name for exosomes, are encapsulated within a single outer membrane. They are released by all cell types and can be found in bile, lymph, serum, stomach acid, synovial fluid, tears, plasma, semen, breast milk, CSF, amniotic fluid, and bronchial fluid. These vesicles serve as pathways for cell communication as they transport proteins and genetic material throughout the body. Technology breakthroughs in exosome separation and analytical techniques, sophisticated exosome applications, expansion of government and non-government initiatives for exosome research, and the rising incidence of cancer are the main reasons propelling the sector.
Despite the negative effects in 2019, the pandemic has created a number of new opportunities for the creation of COVID-19 vaccines and therapies using exosomes, which is anticipated to spur industrial growth in the years to come. For instance, in August 2022, scientists at North Carolina State University created an exosome-based inhalable COVID-19 vaccine. Exosomes can also be used to track the development of a variety of illnesses, including cancer, infectious diseases, neurological illnesses, and cardiovascular diseases (CVDs).
Exosomes' benefits in drug delivery, including their permeability of biological barriers, minimal immunogenicity and toxicity, and stability in circulation, are also expanding the therapeutic uses in this field. Therefore, it is anticipated that the industry would be driven over the projection period by the prospective uses of extracellular vesicles in diagnostics, treatments, and vaccine development. A great demand for efficient new therapeutic alternatives for the detection and treatment of the disease is being created by the rising incidence of cancer. For instance, the World Health Organization (WHO) estimates that approximately 10 million people will die from cancer in 2019, making it one of the leading causes of death globally.
Additionally, the American Cancer Society estimates that by the end of 2022, there would have been 609,360 cancer deaths and 1,918,030 new cancer cases in the United States. Additionally, it is projected that during the projection years, technological developments in exosome isolation and analytical methods would accelerate market growth.
US Exosomes Market is poised to grow at a sustainable CAGR for the next forecast year.
Market snapshot - 2024-2031
Global Market Size
Largest Segment
Diagnostic applications
Fastest Growth
Diagnostic applications
Growth Rate
29.9% CAGR
Global Exosomes Market 2021-2028 ($ Bn)
Country Share for North America Region- 2021 (%)
To get more reports on the above market click here to Buy The Report
Exosomes Market Segmental Analysis
Global Exosomes Market is segmented by product, workflow, application, end-use and region. Based on product, the market is segmented into kits & reagents, instruments and services. Based on workflow, the market is segmented into isolation methods and downstream analysis. Based on application, the market is segmented into cancer, cardiovascular diseases (CVD), neurodegenerative diseases, infectious diseases and others. Based on end-use, the market is segmented into academic & research institutes, pharmaceutical & biotechnology companies and hospitals & clinical testing laboratories. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.
Exosomes Market Analysis by Application
Based on Application, biomarkers emerge as the dominant and largest segment, driven by their pivotal role in diagnostics and prognostics across a diverse array of diseases. Biomarkers hold a significant share due to their utility in providing valuable insights into disease progression and treatment response, thereby fueling their widespread adoption in clinical research and personalized medicine initiatives.
Furthermore, therapeutics emerge as the fastest-growing segment within the exosome market, spurred by the escalating interest in exosome-based therapies for various medical conditions. With their inherent ability to shuttle therapeutic cargo, exosomes offer a promising avenue for targeted drug delivery and regenerative medicine applications. This rapid growth trajectory is propelled by the ongoing research and development efforts aimed at harnessing the therapeutic potential of exosomes, driving innovation and expansion within the market.
Global Exosomes Market Share By Application, 2021 (%)
To get detailed analysis on other segments, Request For Free Sample Report
Exosomes Market Regional Insights
The North American region holds the largest share of the market. The enhanced healthcare infrastructure, efficient government policies, presence of key players, and greater knowledge of diagnostics and healthcare among the populace are all factors that have contributed to the market expansion in this area. Due to a large number of government-funded research studies on the effects of exosome-based drugs on a variety of cancers, including melanoma, breast cancer, lung cancer, and pancreatic cancer, among others, and key players' collaboration with state universities in the area to conduct clinical trials in the United States, the species is likely to remain the most dominant country during the forecast period.
According to projections, Europe will have the second-largest market share. The primary drivers of the market's expansion are the rising incidence of cancer and the considerable per capita healthcare spending by governments. Due to rising cancer occurrences and prevalence in the region, the market in the Asia-Pacific region would experience considerable growth. Because of rising disposable income, increased public awareness of the need for early detection, rising tobacco, and cigarette consumption, and a notable increase in the number of healthcare and diagnostic facilities, the market in Latin America, the Middle East, and Africa will experience moderate growth during the forecast period.
Global Exosomes Market By Geography, 2021 - 2028
- Largest
- Fastest
To know more about the market opportunities by region and country, click here to
Buy The Complete Report
Exosomes Market Dynamics
Exosomes Market Driver
Increasing investments in pharmaceutical R&D and life science research
- Most pharmaceutical, biopharmaceutical, and medical device businesses make significant investments in the creation of new medications and equipment. The pharmaceutical sector invests much in R&D. Pharmaceutical businesses spend in R&D to provide the market with cutting-edge, high-quality goods. According to trends, the leading pharmaceutical firms are enhancing their R&D productivity by significant long-term expenditures in R&D as well as through joint R&D projects.
Exosomes Market Restraint
Lack of standard protocols for the development & production of exosomes
- Exosome research is still in its infancy, and no standards have yet been established. Professionals use new techniques and processes that are available on the market without much reluctance as a result. Exosome research, development, and manufacture provide a number of obstacles for scientists in addition to faults made during exosome creation. Exosomes made from MSCs have attracted a lot of attention lately because they act as intercellular messengers. They are appealing for scientific applications such as vaccine development, cancer diagnostics, cell treatment, gene therapy, and drug administration because of their unusual feature. Thus, in order to create successful exosome harvesting techniques and establish industry-leading standards for exosome characterization and purification, MSC-exosome treatment developers must adapt their stem cell-free therapy process to the new exosome manufacturing needs.
Request Free Customization of this report to help us to meet your business objectives.
Exosomes Market Competitive Landscape
The Global Exosomes market is relatively fragmented, with a high level of competition. Companies are working on new product launches and other initiatives to provide better equipment to their customers and expand their companies globally. These industry leaders are expanding their client base in a variety of ways, and many organizations are forming strategic and creative partnerships with other start-up businesses in order to increase market share and profitability.
Exosomes Market Top Player's Company Profiles
- QIAGEN (Germany)
- Takara Bio Company (Japan)
- Illumina, Inc. (USA)
- Thermo Fisher Scientific, Inc. (USA)
- Codiak Biosciences (USA)
- Exosome Diagnostics (USA)
- Evox Therapeutics (UK)
- ExCoBio Inc. (South Korea)
- Bio-Rad Laboratories Ltd. (USA)
- NanoSomix, Inc. (USA)
- System Biosciences (SBI) (USA)
- Lonza Group (Switzerland)
- Miltenyi Biotec (Germany)
- Norgen Biotek Corp. (Canada)
- AMS Biotechnology (AMSBIO) (UK)
- Creative Biolabs (USA)
- Capricor Therapeutics (USA)
- Aegle Therapeutics (USA)
- Anjarium Biosciences (Switzerland)
Exosomes Market Recent Developments
- In February 2021, Cytiva launched the “Exosome Challenge,” an industry challenge to overcome hurdles in exosome production and manufacturing
- In November 2021, announced the acquisition of the service unit from Exosomics, a leading extracellular vesicles biotech company. The agreement includes Exosomics' service team, service assets, and laboratories in Siena, Italy. The financial details of the deal were not disclosed
Exosomes Key Market Trends
- Exosomes can be used as a treatment platform for a variety of illnesses, including COVID-19. Exosomes are used in medicine to deliver therapeutic cargo components while avoiding immune rejection and cellular toxicity. They are cell-free options for treating a variety of illnesses and for tissue regeneration. Exosomal therapy for respiratory viral infections, including SARS-CoV-2, can be created because stem cell-derived exosomes are favorable in utilizing the anti-inflammatory and regenerative characteristics of parent cells.
Exosomes Market SkyQuest Analysis
SkyQuest’s ABIRAW (Advanced Business Intelligence, Research & Analysis Wing) is our Business Information Services team that Collects, Collates, Co-relates, and Analyses the Data collected utilizing Primary Exploratory Research backed by the robust Secondary Desk research.
According to our Global Exosomes Market Analysis, the potential of exosome technologies has led to an increase in the demand for drug therapies and a surge in R&D activities in the pharmaceutical and biopharmaceutical fields. Exosomes may one day be used to diagnose cancer, and the advancement of translational precision medicine will boost their usage in diagnostic and therapeutic procedures, spurring the development of the exosome diagnostic and therapeutic markets.
| Report Metric | Details |
|---|---|
| Market size value in 2022 | USD 250.8 million |
| Market size value in 2031 | USD 2641.25 million |
| Growth Rate | 29.9% |
| Base year | 2023 |
| Forecast period | 2024-2031 |
| Forecast Unit (Value) | USD Million |
| Segments covered |
|
| Regions covered | North America (US, Canada), Europe (Germany, France, United Kingdom, Italy, Spain, Rest of Europe), Asia Pacific (China, India, Japan, Rest of Asia-Pacific), Latin America (Brazil, Rest of Latin America), Middle East & Africa (South Africa, GCC Countries, Rest of MEA) |
| Companies covered |
|
| Customization scope | Free report customization with purchase. Customization includes:-
|
To get a free trial access to our platform which is a one stop solution for all your data requirements for quicker decision making. This platform allows you to compare markets, competitors who are prominent in the market, and mega trends that are influencing the dynamics in the market. Also, get access to detailed SkyQuest exclusive matrix.
Buy The Complete Report to read the analyzed strategies adopted by the top vendors either to retain or gain market share
Table Of Content
Executive Summary
Market overview
- Exhibit: Executive Summary – Chart on Market Overview
- Exhibit: Executive Summary – Data Table on Market Overview
- Exhibit: Executive Summary – Chart on Exosomes Market Characteristics
- Exhibit: Executive Summary – Chart on Market by Geography
- Exhibit: Executive Summary – Chart on Market Segmentation
- Exhibit: Executive Summary – Chart on Incremental Growth
- Exhibit: Executive Summary – Data Table on Incremental Growth
- Exhibit: Executive Summary – Chart on Vendor Market Positioning
Parent Market Analysis
Market overview
Market size
- Market Dynamics
- Exhibit: Impact analysis of DROC, 2021
- Drivers
- Opportunities
- Restraints
- Challenges
- Exhibit: Impact analysis of DROC, 2021
- SWOT Analysis
KEY MARKET INSIGHTS
- Technology Analysis
- (Exhibit: Data Table: Name of technology and details)
- Pricing Analysis
- (Exhibit: Data Table: Name of technology and pricing details)
- Supply Chain Analysis
- (Exhibit: Detailed Supply Chain Presentation)
- Value Chain Analysis
- (Exhibit: Detailed Value Chain Presentation)
- Ecosystem Of the Market
- Exhibit: Parent Market Ecosystem Market Analysis
- Exhibit: Market Characteristics of Parent Market
- IP Analysis
- (Exhibit: Data Table: Name of product/technology, patents filed, inventor/company name, acquiring firm)
- Trade Analysis
- (Exhibit: Data Table: Import and Export data details)
- Startup Analysis
- (Exhibit: Data Table: Emerging startups details)
- Raw Material Analysis
- (Exhibit: Data Table: Mapping of key raw materials)
- Innovation Matrix
- (Exhibit: Positioning Matrix: Mapping of new and existing technologies)
- Pipeline product Analysis
- (Exhibit: Data Table: Name of companies and pipeline products, regional mapping)
- Macroeconomic Indicators
COVID IMPACT
- Introduction
- Impact On Economy—scenario Assessment
- Exhibit: Data on GDP - Year-over-year growth 2016-2022 (%)
- Revised Market Size
- Exhibit: Data Table on Exosomes Market size and forecast 2021-2027 ($ million)
- Impact Of COVID On Key Segments
- Exhibit: Data Table on Segment Market size and forecast 2021-2027 ($ million)
- COVID Strategies By Company
- Exhibit: Analysis on key strategies adopted by companies
MARKET DYNAMICS & OUTLOOK
- Market Dynamics
- Exhibit: Impact analysis of DROC, 2021
- Drivers
- Opportunities
- Restraints
- Challenges
- Exhibit: Impact analysis of DROC, 2021
- Regulatory Landscape
- Exhibit: Data Table on regulation from different region
- SWOT Analysis
- Porters Analysis
- Competitive rivalry
- Exhibit: Competitive rivalry Impact of key factors, 2021
- Threat of substitute products
- Exhibit: Threat of Substitute Products Impact of key factors, 2021
- Bargaining power of buyers
- Exhibit: buyers bargaining power Impact of key factors, 2021
- Threat of new entrants
- Exhibit: Threat of new entrants Impact of key factors, 2021
- Bargaining power of suppliers
- Exhibit: Threat of suppliers bargaining power Impact of key factors, 2021
- Competitive rivalry
- Skyquest special insights on future disruptions
- Political Impact
- Economic impact
- Social Impact
- Technical Impact
- Environmental Impact
- Legal Impact
Market Size by Region
- Chart on Market share by geography 2021-2027 (%)
- Data Table on Market share by geography 2021-2027(%)
- North America
- Chart on Market share by country 2021-2027 (%)
- Data Table on Market share by country 2021-2027(%)
- USA
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Canada
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Europe
- Chart on Market share by country 2021-2027 (%)
- Data Table on Market share by country 2021-2027(%)
- Germany
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Spain
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- France
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- UK
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Rest of Europe
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Asia Pacific
- Chart on Market share by country 2021-2027 (%)
- Data Table on Market share by country 2021-2027(%)
- China
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- India
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Japan
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- South Korea
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Rest of Asia Pacific
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Latin America
- Chart on Market share by country 2021-2027 (%)
- Data Table on Market share by country 2021-2027(%)
- Brazil
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Rest of South America
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Middle East & Africa (MEA)
- Chart on Market share by country 2021-2027 (%)
- Data Table on Market share by country 2021-2027(%)
- GCC Countries
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- South Africa
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Rest of MEA
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
KEY COMPANY PROFILES
- Competitive Landscape
- Total number of companies covered
- Exhibit: companies covered in the report, 2021
- Top companies market positioning
- Exhibit: company positioning matrix, 2021
- Top companies market Share
- Exhibit: Pie chart analysis on company market share, 2021(%)
- Total number of companies covered
Methodology
For the Exosomes Market, our research methodology involved a mixture of primary and secondary data sources. Key steps involved in the research process are listed below:
1. Information Procurement: This stage involved the procurement of Market data or related information via primary and secondary sources. The various secondary sources used included various company websites, annual reports, trade databases, and paid databases such as Hoover's, Bloomberg Business, Factiva, and Avention. Our team did 45 primary interactions Globally which included several stakeholders such as manufacturers, customers, key opinion leaders, etc. Overall, information procurement was one of the most extensive stages in our research process.
2. Information Analysis: This step involved triangulation of data through bottom-up and top-down approaches to estimate and validate the total size and future estimate of the Exosomes Market.
3. Report Formulation: The final step entailed the placement of data points in appropriate Market spaces in an attempt to deduce viable conclusions.
4. Validation & Publishing: Validation is the most important step in the process. Validation & re-validation via an intricately designed process helped us finalize data points to be used for final calculations. The final Market estimates and forecasts were then aligned and sent to our panel of industry experts for validation of data. Once the validation was done the report was sent to our Quality Assurance team to ensure adherence to style guides, consistency & design.
Analyst Support
Customization Options
With the given market data, our dedicated team of analysts can offer you the following customization options are available for the Exosomes Market:
Product Analysis: Product matrix, which offers a detailed comparison of the product portfolio of companies.
Regional Analysis: Further analysis of the Exosomes Market for additional countries.
Competitive Analysis: Detailed analysis and profiling of additional Market players & comparative analysis of competitive products.
Go to Market Strategy: Find the high-growth channels to invest your marketing efforts and increase your customer base.
Innovation Mapping: Identify racial solutions and innovation, connected to deep ecosystems of innovators, start-ups, academics, and strategic partners.
Category Intelligence: Customized intelligence that is relevant to their supply Markets will enable them to make smarter sourcing decisions and improve their category management.
Public Company Transcript Analysis: To improve the investment performance by generating new alpha and making better-informed decisions.
Social Media Listening: To analyze the conversations and trends happening not just around your brand, but around your industry as a whole, and use those insights to make better Marketing decisions.
USA (+1) 351-333-4748
